These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30850533)

  • 1. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.
    Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
    Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis.
    Merle NS; Grunenwald A; Figueres ML; Chauvet S; Daugan M; Knockaert S; Robe-Rybkine T; Noe R; May O; Frimat M; Brinkman N; Gentinetta T; Miescher S; Houillier P; Legros V; Gonnet F; Blanc-Brude OP; Rabant M; Daniel R; Dimitrov JD; Roumenina LT
    Front Immunol; 2018; 9():179. PubMed ID: 29545789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.
    May O; Merle NS; Grunenwald A; Gnemmi V; Leon J; Payet C; Robe-Rybkine T; Paule R; Delguste F; Satchell SC; Mathieson PW; Hazzan M; Boulanger E; Dimitrov JD; Fremeaux-Bacchi V; Frimat M; Roumenina LT
    Front Immunol; 2018; 9():3008. PubMed ID: 30619356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Toll-like receptor 4 in intravascular hemolysis-mediated injury.
    Vázquez-Carballo C; Herencia C; Guerrero-Hue M; García-Caballero C; Rayego-Mateos S; Morgado-Pascual JL; Opazo-Rios L; González-Guerrero C; Vallejo-Mudarra M; Cortegano I; Gaspar ML; de Andrés B; Egido J; Moreno JA
    J Pathol; 2022 Nov; 258(3):236-249. PubMed ID: 35903022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.
    Merle NS; Leon J; Poillerat V; Grunenwald A; Boudhabhay I; Knockaert S; Robe-Rybkine T; Torset C; Pickering MC; Chauvet S; Fremeaux-Bacchi V; Roumenina LT
    Front Immunol; 2020; 11():1772. PubMed ID: 32849636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.
    Frimat M; Tabarin F; Dimitrov JD; Poitou C; Halbwachs-Mecarelli L; Fremeaux-Bacchi V; Roumenina LT
    Blood; 2013 Jul; 122(2):282-92. PubMed ID: 23692858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemopexin as an Inhibitor of Hemolysis-Induced Complement Activation.
    Poillerat V; Gentinetta T; Leon J; Wassmer A; Edler M; Torset C; Luo D; Tuffin G; Roumenina LT
    Front Immunol; 2020; 11():1684. PubMed ID: 32849588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
    Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
    Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury.
    Farrar CA; Wang Y; Sacks SH; Zhou W
    Am J Pathol; 2004 Jan; 164(1):133-41. PubMed ID: 14695327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8 acts as an autocrine priming signal for heme-induced human Mϕ pro-inflammatory responses in hemolytic inflammation.
    Silveira AAA; Mahon OR; Cunningham CC; Corr EM; Mendonça R; Saad STO; Costa FF; Dunne A; Conran N
    J Leukoc Biol; 2019 Jul; 106(1):35-43. PubMed ID: 31091351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Reactive Oxygen Species Participate in Signaling Triggered by Heme in Macrophages and upon Hemolysis.
    Prestes EB; Alves LS; Rodrigues DAS; Dutra FF; Fernandez PL; Paiva CN; Kagan JC; Bozza MT
    J Immunol; 2020 Nov; 205(10):2795-2805. PubMed ID: 33037139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Component C5 and TLR Molecule CD14 Mediate Heme-Induced Thromboinflammation in Human Blood.
    Thomas AM; Gerogianni A; McAdam MB; Fløisand Y; Lau C; Espevik T; Nilsson PH; Mollnes TE; Barratt-Due A
    J Immunol; 2019 Sep; 203(6):1571-1578. PubMed ID: 31413105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia.
    Hanson MS; Xu H; Flewelen TC; Holzhauer SL; Retherford D; Jones DW; Frei AC; Pritchard KA; Hillery CA; Hogg N; Wandersee NJ
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H328-36. PubMed ID: 23125208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme Causes Pain in Sickle Mice
    Lei J; Paul J; Wang Y; Gupta M; Vang D; Thompson S; Jha R; Nguyen J; Valverde Y; Lamarre Y; Jones MK; Gupta K
    Antioxid Redox Signal; 2021 Feb; 34(4):279-293. PubMed ID: 32729340
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.
    Vinchi F; De Franceschi L; Ghigo A; Townes T; Cimino J; Silengo L; Hirsch E; Altruda F; Tolosano E
    Circulation; 2013 Mar; 127(12):1317-29. PubMed ID: 23446829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.